August 26/White Plains, N.Y./PRNewswire -- Bunge Limited announced that Jacqualyn A. Fouse, chief financial officer, will be leaving the company effective September 24, 2010, to become CFO of Celgene Corporation, a global biopharmaceutical company. Bunge has initiated a search for Fouse's replacement. Andrew J. Burke, the company's global Operational excellence officer, will serve as interim CFO.
"Jackie has made many contributions to Bunge during her tenure. She spearheaded initiatives to increase efficiency and provided valuable leadership during a particularly volatile time in our markets and the global economy," said Alberto Weisser, chairman and chief executive officer, Bunge Limited. "I would like to express our appreciation and wish her success in her future endeavors. At the same time, I am pleased that Drew will serve as interim CFO. He is a highly experienced executive with strong finance and operational expertise. Given his deep knowledge of Bunge, we expect a smooth transition."